Jennifer Cote - Dec 29, 2024 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role: Chief Financial Officer
Signature: /s/ David Sirois, by power of attorney
Stock symbol: HBIO
Transactions as of: Dec 29, 2024
Transactions value $: -$16,885
Form type: 4
Date filed: 12/31/2024, 04:01 PM
Previous filing: Mar 7, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HBIO	Common Stock	Tax liability	-$9.37K	-4.73K	-2.8%	$1.98	164K	Dec 29, 2024	Direct	F1
transaction	HBIO	Common Stock	Tax liability	-$7.52K	-3.8K	-2.32%	$1.98	160K	Dec 29, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit ("RSU") awards previously granted to the Reporting Person that vested in part on December 29, 2024.
F2	Includes (a) 8,964 RSUs that will vest on December 29, 2025, (b) 35,800 RSUs that will vest in three equal installments on March 19, 2025, 2026 and 2027, (c) 35,800 RSUs with performance based vesting conditions tied to achievements by the Company of certain performance criteria, (d) 25,862 RSUs with performance based vesting conditions tied to relative total shareholder return and (e) 53,784 shares of common stock beneficially owned by the Reporting Person.

Content

The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit ("RSU") awards previously granted to the Reporting Person that vested in part on December 29, 2024.

Includes (a) 8,964 RSUs that will vest on December 29, 2025, (b) 35,800 RSUs that will vest in three equal installments on March 19, 2025, 2026 and 2027, (c) 35,800 RSUs with performance based vesting conditions tied to achievements by the Company of certain performance criteria, (d) 25,862 RSUs with performance based vesting conditions tied to relative total shareholder return and (e) 53,784 shares of common stock beneficially owned by the Reporting Person.